Biotech Phase Trial Readout Social Video Response Script

Role: Lead Biotech Crisis Communications and Investor Relations Strategist.

Context

• Investigational asset: {{pipeline_drug_name}}
• Indication and phase: {{trial_phase_indication}}
• Primary endpoint findings: {{primary_endpoint_result}}
• Secondary endpoint context: {{secondary_endpoint_nuance}}
• Primary stakeholder skepticism: {{market_concern_theme}}
• Detailed regulatory filing link: {{investor_portal_link}}

Task

Author a high-stakes, 90-second executive video response script for social channels delivering transparent analysis of clinical data for {{pipeline_drug_name}} in {{trial_phase_indication}}, neutralizing {{market_concern_theme}} with scientific rigor.

Method

1. Deconstruct {{market_concern_theme}} to address genuine scientific questions while maintaining executive authority.
2. Open the video script with an empathetic acknowledgement of patient need in {{trial_phase_indication}} before transitioning to data.
3. Present {{primary_endpoint_result}} with absolute transparency, explicitly stating statistical significance parameters.
4. Contextualize the clinical readout using {{secondary_endpoint_nuance}} to highlight the holistic patient impact without cherry-picking.
5. Address {{market_concern_theme}} head-on using balanced, defensible clinical interpretations.
6. Provide detailed stage directions, posture notes, and teleprompter inflection cues to ensure an authentic, calm delivery.
7. Conclude with a transparent summary of regulatory milestones and direct viewers to {{investor_portal_link}} for full safety datasets.

Constraints

• Script MUST comply with Reg FD, SEC disclosure standards, and FDA promotional communication boundaries.
• The speaker MUST NOT speculate on future regulatory approval dates, target share prices, or unverified subgroup analyses.
• Total spoken duration must stay between 80 and 95 seconds (200-240 spoken words maximum).
• The tone must remain objective, scientifically grounded, and transparent rather than defensive or overly promotional.

Output format

1. Executive Setup: Delivery tone, background setting, teleprompter pacing guide, and wardrobe direction.
2. Three-Part Production Script:
   • Part I: Mission Reaffirmation & Primary Readout (0:00-0:30)
   • Part II: Nuance & Addressing {{market_concern_theme}} (0:30-1:05)
   • Part III: Path Forward & Resource Disclosure (1:05-1:30)
3. Accompanying Social Post Copy: Compliant executive post text (under 120 words) with mandatory safe harbor disclaimer and {{investor_portal_link}}.

Self-review

• Ensure no forward-looking statements violate securities disclosure or life sciences advertising regulations.
• Confirm {{primary_endpoint_result}} and {{secondary_endpoint_nuance}} are presented without misleading omission of safety data.
• Verify that the response to {{market_concern_theme}} directly addresses investor and clinician concerns with credible data.